Header search > ticker > Open Stock TerminalSelect the market and trading date first when you need a specific listing or historical session.
TradingFloor AI · Stock TerminalBIIB - Ticker AI Digest
Biogen Inc 📰 2
US500
218.50000000
| Today -1.35%
●
Important AI Risk Notice
Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.
Not investment advice.
Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate.
Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only.
Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally.
Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Biogen Inc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
BIIB
Data 2026-08-31
Preview Mode
Core Deck
Deep Dive Modules
Digested News
Today's Catalysts (BIIB) 2
AI 1
Acquisitions 0
Admission 0
Agreement 2
Approvals 0
Authorisation 0
Awards 0
BTC 0
BlockListing 0
Blockchain 0
Breakthrough 0
BuyBack 0
Cancellations 0
CashOffer 0
Circular 0
ClinicalTrial 0
Collaborate 0
ContractWin 0
Covid-19 0
Deals 4
Diamond 0
DirectorDealing 0
DirectorateChange 0
Discovery 0
Dividend 0
Exceeded 0
FCA 0
FDA 2
Form83 0
GeneralMeeting 0
Grants 0
InvestmentPlan 0
IssueOfEquity 0
JV 0
Launch 1
Litigation 0
MonthlyFactsheet 0
NAV 0
NameChange 0
NewContract 0
Offers 0
Offtake 0
Orders 0
OwnShares 0
Partner 0
Patents 1
Placing 0
Positive 0
ProfitWarning 0
Proposals 0
Prospectus 0
Reports 1
Results 0
SchemeOfArrangement 0
Significant 0
Speculation 0
Strategic 0
Suspension 0
TR1 0
TVR 0
Takeover 0
US News 0
Understanding 0
Updates 1
Vaccine 0
Wins 0
Worth 0
All Market News (Last 30 Days) 50
BIIB
11:59
Biogen Inc
BIIB
07:22
Biogen Inc
BIIB
10:00
Biogen Inc
BIIB
09:59
Biogen Inc
BIIB
14:37
Biogen Inc
BIIB
11:15
Biogen Inc
BIIB
20:58
Biogen Inc
BIIB
16:00
Biogen Inc
BIIB
11:30
Biogen Inc
BIIB
12:05
Biogen Inc
BIIB
08:09
Biogen Inc
BIIB
09:39
Biogen Inc
BIIB
21:45
Biogen Inc
BIIB
12:05
Biogen Inc
BIIB
16:31
Biogen Inc
Today's AI
BIIB · Agentic Market Intelligence
BIIB intelligence is listening.
The engine is monitoring news, price structure, forecasts and financial changes. New scored evidence will appear here against this stock automatically.
AI bias0.0
Bullish0
Bearish0
Today's AI Starts With News
2 live catalysts is opening Today’s AI for BIIB.
Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape
Data 2026-08-31
Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
2
Today
Front Of Desk
Biogen Inc has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
BIIB signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.
This is the ticker-specific Today’s AI desk for Biogen Inc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.
Subscription Required
Bullish vs Bearish Scoring
AI + Financial Blend
Buy / Sell Trigger Engine
Today's AI Findings
Subscriber Unlock
Subscribe to unlock the full BIIB Today’s AI cockpit.
Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.
- AI-scored market headlines with sentiment buckets and buzzword breakdowns.
- Forecast leaders ranked by projected gain against current market price.
- Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
- Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
- Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
- Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for BIIB on 2026-08-31.
Fundamentals Matrix
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for aRelapsed or refractory diffuse large B-cell lymphoma; and other anti-CD20 therapies. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; UCB; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and Sage Therapeutics, Inc., as well as collaborations with Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome; Dayra Therapeutics, Inc. to develop oral macrocyclic peptides; Vanqua Bio, Inc. for developing Vanqua's preclinical oral C5aR1 antagonist compound; City Therapeutics, Inc. to develop select novel RNAi therapies; and ALTEOGEN Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
30.8B
Enterprise Value
34.2B
Public Float
99.7
Broker Target
220.2845
Shares Out
147.6M
Long Interest
0
Short Interest
0
Exchange
NASDAQ
Currency Code
USD
ISIN
US09062X1037
Ex-Dividend
-
Yield
0.00%
Dividend Rate
-
EPS
9.29
Index
S&P 500
Market
NASDAQ
Standard Lists
US500
Sector
Pharmaceuticals and BiotechnologyUS fundamentals
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-
Financials Matrix
News And Alerts First
2 live alerts now opens the financials desk for BIIB.
Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts
Data 2026-08-31
Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
2
Alerts
Front Of Desk
Biogen Inc has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
-
Earnings Date
-
Net Debt
3.9B
Cash
3.0B
EPS
9.29
Net Income
1.3B
Revenue
9.9B
Enterprise Value
34.2B
Trailing PE
22.4392
Forward PE
15.4799
Price Sales TTM
3.097
Price Book MRQ
1.7107
EV Revenue
3.4402
EV EBITDA
12.6654
Financial Forecastist
Improving financial engine
Revenue is accelerating +1.9% against the prior comparable period. Net margin is expanding by 3.0 pts. Net debt is coming down +21.0%.
Revenue +1.9%
Net Income +32.8%
FCF +228.3%
Current Ratio 3.06x
Forward Rev 2.6B
Improving
Quarter Revenue
2.5B
+1.9%
vs prior comparable quarter
Net Margin
+12.9%
+3.0 pts
profitability pulse
Free Cash Flow
696.7M
+228.3%
cash conversion
Net Debt / EBITDA
5.7x
-21.0%
lower is cleaner
Revenue Engine
Latest quarter printed 2.5B with the top line pushing higher against the last comparable period.
Profit Stack
Net income landed at 319.5M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.
Balance-Sheet Pressure
Cash sits near 3.4B while net debt is 3.2B. The leverage stack is cleaning up.
Quarterly Revenue Runway
Actual revenue bars, consensus revenue where available, plus the terminal model path.
Profit And Cash Conversion
Net income and free cash flow moving together is usually what separates genuine improvement from noise.
Balance-Sheet Pressure
Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.
Annual Power Curve
Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2025
Consensus
2.3B
Revenue Path
3.88
EPS / Earnings
Growth cue -0.0%
Q1 2026
Consensus
2.2B
Revenue Path
2.95
EPS / Earnings
Growth cue -0.0%
Q2 2026
Consensus
2.4B
Revenue Path
2.09
EPS / Earnings
Growth cue -0.6%
Q3 2026
Consensus
2.6B
Revenue Path
3.94
EPS / Earnings
Growth cue -0.2%
FY 2026
Consensus
10.1B
Revenue Path
13.32
EPS / Earnings
Growth cue -0.1%
FY 2027
Consensus
10.4B
Revenue Path
16.63
EPS / Earnings
Growth cue +0.2%
Quarterly Statement Tape
Last 6 Quarters
| Period | Revenue | Net Income | FCF | Net Debt |
|---|---|---|---|---|
| Q1 2026 | 2.5B | 319.5M | 696.7M | 3.2B |
| Q4 2025 | 2.3B | -48.4M | 555.9M | 3.9B |
| Q3 2025 | 2.5B | 466.5M | 1.2B | 2.7B |
| Q2 2025 | 2.6B | 634.8M | 144.3M | 3.8B |
| Q1 2025 | 2.4B | 240.5M | 212.2M | 4.0B |
| Q4 2024 | 2.5B | 266.7M | 694.6M | 4.3B |
Annual Financial Power
Last 5 Years
| Period | Revenue | Net Income | EBITDA | FCF |
|---|---|---|---|---|
| FY 2025 | 9.8B | 1.3B | 3.1B | 2.1B |
| FY 2024 | 9.7B | 1.6B | 3.0B | 2.5B |
| FY 2023 | 9.8B | 1.2B | 2.4B | 1.2B |
| FY 2022 | 10.2B | 3.0B | 3.5B | 1.1B |
| FY 2021 | 11.0B | 1.6B | 3.9B | 3.3B |
Structure DNA
Market Structure DNA
Balanced Structure profile with trend runway open
Price is 88.6% through the 52-week range, +6.5% vs 50DMA and +17.4% vs 200DMA. 96.5% of the register is locked by institutions and insiders, leaving 3.5% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.
Trend runway open
Institutional gravity
Moderate income rhythm
As Of 2026-07-07
Balanced Structure
Structure Score
69.0 / 100
Balanced Structure
Trend Stack
+6.5% / +17.4%
vs 50DMA / 200DMA
52W Position
88.6%
auction position inside the yearly range
Ownership Lock
96.5%
96.3% institutions | 18.8% insiders
Pressure Pocket
3.9% short float
Short ratio 5.2x | monthly +8.7%
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway
Implied spot is 208.46 with the stock +6.5% vs 50DMA and +17.4% vs 200DMA. The tape is sitting 88.6% through the 52-week range, which frames the regime as trend runway open.
Ownership Register
Institutions hold about 96.3% and insiders about 18.8%, locking roughly 96.5% of the register and leaving 3.5% in free float. That reads as institutional gravity.
Pressure Pocket
Short pressure is running near 3.9% of float with short ratio 5.2x and monthly change +8.7%. That gives us a read on whether the tape is clean, crowded, or coiled.
Capital Rhythm
Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.
Structure Score
One-glance gauge for the current market-structure regime.
Pillar Radar
Trend, ownership, pressure, and capital rhythm mapped on one wheel.
Position And Float Balance
Shows whether the stock is extended, tightly held, or carrying capital-return support.
Dividend Cadence Tape
Historical dividend-event counts help reveal how dependable the income rhythm has been.
Dividend Cadence Ledger
No cadence
| Year | Dividend Count | Context |
|---|---|---|
| Dividend history has not been normalized yet. | ||
Structure Facts
Live Snapshot
Implied Spot
208.46
derived from market cap / shares
52W High
219.72
upper auction edge
52W Low
121.05
lower auction edge
Beta
0.16
volatility character
Shares Out
147.6M
fully diluted count
Shares Float
147.2M
tradable register
Shares Short
5.2M
borrowed stock
Short Ratio
5.2x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
3:1
2001-01-18
Capital Radar
Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
105.5927
Institutions As Of
2026-05-31
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
40
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder
Short Data · BIIB · Last 30 Days
Short D · 12/26 EMA spread with 9 signal
Red histogram bars show short loading accelerating. Green bars show short covering accelerating. The two lines expose the crossover before the raw holder table does.
Short D waiting
Building BIIB short-momentum read
Short D compares the ticker’s disclosed short-position momentum with its own signal line.
Short D—
Signal—
Momentum—
Declared Short Holders
Nexus Pulse Engine
Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending
Volatility Lab
ATR(14)
Realized Vol (20d)
Volume Spike Z
AI Charts
News And Alerts First
The alert tape opens the door for BIIB, and AI Charts sits just below.
Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape
Data 2026-08-31
AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
2
Today
Catalyst Pulse
Biogen Inc has fresh news flow live now, so the tape is framing the chart workspace below.
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.
Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.
Automated Signalling
Automated AI Forecasts
Predictive MACD
Catalyst Beacons
Live Price Structure
AI AutoDetection
Automatic bull / bear chart read
Detected market structure
Analysing selected range
Why this call
Waiting for sufficient price history.
Invalidation
—
Updates with the timeframe.
Bull caseCalculating upside confirmation.
Bear caseCalculating downside confirmation.
AI Forecast -16.61%
RSI Gauge
Price Change
AI Forecast